Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza, Egypt.
Recent Pat Biotechnol. 2023;17(4):312-331. doi: 10.2174/1872208317666221017094715.
The world is on the cusp of a post-antibiotic period. A century ago, before the advent of antibiotics, bacteriophage therapy was the treatment of choice for bacterial infections. Although bacteriophages have yet to be approved as a treatment in Western medicine, researchers and clinicians have begun to anticipate phage therapy. Bacteriophages are viruses that depend on bacterial cell metabolism to multiply. They offer a promising alternative to the use of antibiotics and an excellent antibacterial option for combating multidrug resistance in bacteria. However, not every phage is suitable for phage therapy. In particular, prophages should not be used because they can lysogenize host cells instead of lysing them. To offer adequate therapeutic options for patients suffering from various infectious diseases, a wide selection of different phages is needed. While there is no evidence of direct toxicity induced by phage particles, it is crucial to study mammalian cell-phage interactions. This requires phage preparations to be free of bacterial cells, toxins and other compounds to avoid skewing host responses. Negative staining of purified viruses and electron microscopy remain the gold standard in the identification of bacteriophages. Interestingly, genomics has greatly changed our understanding of phage biology. Bacteriophage genome sequencing is essential to obtain a complete understanding of the bacteriophages' biology and to obtain confirmation of their lifestyle. Full genetic sequencing of bacteriophage will enable a better understanding of the phage-encoded proteins and biomolecules (especially phage lytic enzymes) involved in the process of bacterial cell lysis and death. Mass spectrometry can be used for the identification of phage structural proteins. The use of lytic phages as biocontrol agents requires the most appropriate and standard methods to ensure application safety. This review pursues recent research and methods in molecular biology for the isolation and characterization of phages to facilitate follow-up and implementation of work for other researchers. Patents related to this topic have been mentioned in the text.
当今世界正处在后抗生素时代的边缘。一个世纪以前,在抗生素问世之前,噬菌体疗法是治疗细菌感染的首选方法。尽管噬菌体尚未被西方医学批准为一种治疗方法,但研究人员和临床医生已经开始期待噬菌体疗法。噬菌体是一种依赖细菌细胞代谢进行繁殖的病毒。它们为抗生素的使用提供了一种很有前途的替代方法,并且是对抗细菌多重耐药性的一种极好的抗菌选择。然而,并非每一种噬菌体都适合用于噬菌体治疗。特别是,不应使用原噬菌体,因为它们可以溶原化宿主细胞而不是裂解它们。为了为患有各种传染病的患者提供足够的治疗选择,需要广泛选择不同的噬菌体。虽然没有证据表明噬菌体颗粒会直接引起毒性,但研究哺乳动物细胞-噬菌体相互作用至关重要。这需要噬菌体制剂不含细菌细胞、毒素和其他化合物,以避免影响宿主反应。纯化病毒的负染色和电子显微镜仍然是鉴定噬菌体的金标准。有趣的是,基因组学极大地改变了我们对噬菌体生物学的理解。噬菌体基因组测序对于全面了解噬菌体生物学以及确认其生活方式至关重要。噬菌体的全基因组测序将使我们更好地理解噬菌体编码的蛋白质和生物分子(特别是噬菌体裂解酶)在细菌细胞裂解和死亡过程中所起的作用。质谱可用于鉴定噬菌体的结构蛋白。溶菌噬菌体作为生物防治剂的使用需要最适当和标准的方法来确保应用安全。本综述旨在探讨分子生物学领域中分离和鉴定噬菌体的最新研究和方法,以促进其他研究人员的后续工作和实施。本文还提到了与该主题相关的专利。